Immunotherapy for Limited-Stage Small Cell Lung Cancer: Innovative Treatments and Future Perspectives
{{output}}
BackgroundLimited-stage small cell lung cancer (LS-SCLC) is a highly aggressive tumor characterized by a poor prognosis. While concurrent chemoradiotherapy (CCRT) remains the standard treatment, the high rates of recurrence and poor long-term survival highligh... ...
